Advertisement
GCTK vs SINT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a Buy and SINT is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GCTK’s FA Score shows that 0 FA rating(s) are green whileSINT’s FA Score has 1 green FA rating(s).
- GCTK’s FA Score: 0 green, 5 red.
- SINT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GCTK’s TA Score shows that 5 TA indicator(s) are bullish while SINT’s TA Score has 4 bullish TA indicator(s).
- GCTK’s TA Score: 5 bullish, 5 bearish.
- SINT’s TA Score: 4 bullish, 5 bearish.
Price Growth
GCTK (@Pharmaceuticals: Other) experienced а -11.18% price change this week, while SINT (@Medical/Nursing Services) price change was +7.58% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.61%. For the same industry, the average monthly price growth was +3.37%, and the average quarterly price growth was +9.80%.
Industries' Descriptions
@Pharmaceuticals: Other (-1.23% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.61% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| GCTK | SINT | GCTK / SINT | |
| Capitalization | 5.5M | 12.5M | 44% |
| EBITDA | -22.78M | -11.59M | 196% |
| Gain YTD | -98.633 | 29.714 | -332% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 0 | 950K | - |
| Total Cash | 9.56M | 4.32M | 221% |
| Total Debt | 267K | 3.53M | 8% |
GCTK | SINT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 97 | 93 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | 37 | |
P/E GROWTH RATING 1..100 | 100 | 4 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SINT's Valuation (56) in the Medical Specialties industry is somewhat better than the same rating for GCTK (96) in the null industry. This means that SINT’s stock grew somewhat faster than GCTK’s over the last 12 months.
SINT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that SINT’s stock grew similarly to GCTK’s over the last 12 months.
SINT's SMR Rating (100) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that SINT’s stock grew similarly to GCTK’s over the last 12 months.
SINT's Price Growth Rating (37) in the Medical Specialties industry is in the same range as GCTK (64) in the null industry. This means that SINT’s stock grew similarly to GCTK’s over the last 12 months.
SINT's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for GCTK (100) in the null industry. This means that SINT’s stock grew significantly faster than GCTK’s over the last 12 months.
| GCTK | SINT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 82% |
| Advances ODDS (%) | 2 days ago 78% | 3 days ago 84% |
| Declines ODDS (%) | 4 days ago 90% | 10 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 81% |
Advertisement
GCTK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GCTK has been closely correlated with BNR. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if GCTK jumps, then BNR could also see price increases.
| Ticker / NAME | Correlation To GCTK | 1D Price Change % | ||
|---|---|---|---|---|
| GCTK | 100% | +5.70% | ||
| BNR - GCTK | 78% Closely correlated | N/A | ||
| SINT - GCTK | 75% Closely correlated | -7.54% | ||
| APDN - GCTK | 72% Closely correlated | -2.02% | ||
| SSKN - GCTK | 70% Closely correlated | -7.98% | ||
| AIMD - GCTK | 34% Loosely correlated | +2.63% | ||
More | ||||
SINT and
Correlation & Price change
A.I.dvisor indicates that over the last year, SINT has been closely correlated with SSKN. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SINT jumps, then SSKN could also see price increases.
| Ticker / NAME | Correlation To SINT | 1D Price Change % | ||
|---|---|---|---|---|
| SINT | 100% | -7.54% | ||
| SSKN - SINT | 85% Closely correlated | -7.98% | ||
| APDN - SINT | 84% Closely correlated | -2.02% | ||
| GCTK - SINT | 75% Closely correlated | +5.70% | ||
| STSS - SINT | 63% Loosely correlated | -3.49% | ||
| AIMD - SINT | 41% Loosely correlated | +2.63% | ||
More | ||||